Bioregate Forum is a biannual European meeting dedicated to highlighting latest scientific, technological, clinical & commercialization approaches in the field of cell & gene therapy, stem cells, biomaterials and tissue engineering.
Its ambition is to is to enhance links between researchers, clinicians, industrials and institutional stakeholders and to bring together R&D from pharmaceutical companies and academic-driven phase I clinical trials to stimulate collaboration between those two worlds.
The first edition of Bioregate Forum will be held in Nantes, France and will focus on cell therapy with embryonic and pluripotent stem cells, cell therapy with biomaterials for bone repair, cell immunotherapy and stem cells for drug discovery, + a round table on the regulation and reimbursement changes for these advanced therapies. The event will feature presentations and interactive sessions, led by experts from research and from biotech & pharma industry.
Do not miss:
The 2 days of conferences, round tables, workshops with high level scientists, clinicians and industrials: a great opportunity to present and discuss your organisation’s latest achievements in research, innovation, clinical trials or market access approaches
Meet over 200 delegates from Europe: experts from research and from biotech & pharma industry
The exhibition area
The poster session
The Gala dinner in a prestigious location of Nantes
Some of 2016 keynote speakers:
Pr Philippe Menasche, Department of Cardiovascular Surgery, Georges Pompidou European Hospital, Paris, France
Dr Arnaud Lacoste, Novartis Institutes for BioMedical Research, Inc, Cambridge MA, USA
Pr Christian Jorgensen, Regenerative Medicine Institute, Université de Montpellier, France
Pr Jean-Sébastien Hulot, Institute of Cardiometabolism & Nutrition, Université Pierre et Marie Curie, France
Programme | Registration | Call for abstracts | Sponsorship –> now open on www.bioregate-forum.com
Early bird registration rates available until June 15th!